Longer DAPT Better After Stenting

November 16, 2014 10:19 PM

12 0

CHICAGO -- Continuing a thienopyridine plus aspirin well beyond 1 year cut major adverse cardiovascular risks after drug-eluting stent (DES) implantation in the landmark Dual Antiplatelet Therapy (DAPT) trial.

Dual therapy for 30 months cut stent thrombosis rates by a relative 71% compared with aspirin alone after 12 months (rate 0.4% versus 1.4% from months 12 to 30, P<0.001), Laura Mauri, MD, of Brigham and Women's Hospital in Boston, and colleagues found.

Read more

To category page